Study: Kim 2026, International Journal of Stem Cells
Efficacy and Safety of Low-Molecular-Weight Collagen Peptide GT for Improving Hair Condition in Individuals with Damaged Hair: A Randomized, Double-Blind, Placebo-Controlled Trial
Citation
Kim TK, Oh J, Ha YS, Son HJ et al (2026). International Journal of Stem Cells. PubMed id 42624827.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Collagen for hair, nails and joints Tier B thin
B Korean adults aged 19 to 60 with mild to moderate hair damage and no alopecia (number not given in the abstract) (n=not recorded)
Randomised double-blind placebo-controlled trial, 3 g/day low-molecular-weight collagen peptide for 24 weeks.
Compared with placebo, hair gloss, elasticity (tensile strength) and diameter improved, and scalp elasticity rose. No treatment-related adverse events.
As recorded in this card: Kim TK, Oh J, Ha YS, Son HJ et al (2026), International Journal of Stem Cells, [primary]
Note: Hair damage, not hair loss or growth. One branded peptide. Hair type and funding not in the abstract.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.